A study conducted by researchers from Cedars-Sinai has found that the simple process of counting how many lymph nodes (LNs) are cancerous may be the best option to determine cancer patient’s disease outlook and mortality for 16 major cancers.
“Count the number of metastatic [cancerous] lymph nodes,” co-author Assoc Prof. Zack Zumsteg said. “We found that this simple process is much better for determining prognoses for solid tumors than all the other factors used today.”
